{"id":984044,"date":"2026-07-23T07:38:33","date_gmt":"2026-07-23T11:38:33","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\/"},"modified":"2026-07-23T07:38:33","modified_gmt":"2026-07-23T11:38:33","slug":"kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\/","title":{"rendered":"Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm"},"content":{"rendered":"

<\/p>\n

Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm<\/b><\/p>\n

PHILADELPHIA–(BUSINESS WIRE<\/a>)–
\nInvestor litigation firm Kaskela Law<\/a> announces that it is investigating Integra LifeSciences Holdings Corp. (NASDAQ: IART) (\u201cIntegra\u201d) on behalf of the company\u2019s long-term investors.<\/p>\n

Click here for additional information: <\/i><\/b>https:\/\/kaskelalaw.com\/cases\/integra-lifesciences\/<\/i><\/b><\/a><\/p>\n

\nRecently a securities fraud complaint was filed against Integra on behalf of investors who purchased shares of the company\u2019s stock between March 11, 2019 and May 22, 2023<\/i><\/b> (the \u201cWrongdoing Period\u201d). According to the complaint, during the Wrongdoing Period, the company issued a series of materially false and misleading statements to investors concerning \u201cIntegra\u2019s systemic, serious, and recurring violations of current Good Manufacturing Practices (\u201ccGMP\u201d), which are foundational FDA regulations governing product quality and safety in connection with the manufacture of the Company\u2019s biologic mesh.\u201d<\/p>\n

\nAs further detailed in the complaint, on July 29, 2024, Integra disclosed systemic cGMP deficiencies and shipping holds across all Company facilities, requiring the company to implement a company-wide \u201ccompliance master plan to address quality system and cGMP learnings.\u201d Significantly, the \u201ccompliance master plan\u201d required a complete production halt on all of Integra\u2019s key product lines. In response to this disclosure, Integra\u2019s stock price declined 21% in value.<\/i><\/b><\/p>\n

\nThe investigation seeks to determine whether the members of Integra\u2019s board of directors violated the securities laws and\/or breached their fiduciary duties in connection with the above alleged misconduct.<\/p>\n

Current Integra shareholders who purchased or acquired their IART shares prior to April 26, 2023<\/span> are encouraged to contact <\/i>Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) for additional information about this investigation and their legal rights and options at (484) 229 \u2013 0750, by email at <\/i><\/b>abell@kaskelalaw.com<\/i><\/b><\/a>, or online at:<\/i><\/b><\/p>\n

https:\/\/kaskelalaw.com\/cases\/integra-lifesciences\/<\/i><\/b><\/a><\/p>\n

ABOUT KASKELA LAW:<\/span><\/b><\/p>\n

\nKaskela Law LLC exclusively<\/span><\/i> represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis (i.e.<\/i>, the firm\u2019s clients are never responsible for any out-of-pocket costs for legal representation). Since 2020, the firm has helped to recover over $500 million for investors. For additional information about Kaskela Law LLC, including the firm\u2019s recent notable recoveries for investors, please visit www.kaskelalaw.com<\/a>.<\/p>\n

\nThis communication may constitute attorney advertising in certain jurisdictions.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20260723585891\/en\/<\/a><\/span><\/p>\n

KASKELA LAW LLC
\n<\/b>
D. Seamus Kaskela, Esq.
\n
(skaskela@kaskelalaw.com<\/a>)
\n
Adrienne Bell, Esq.
\n
(abell@kaskelalaw.com<\/a>)
\n
18 Campus Blvd., Suite 100
\n
Newtown Square, PA 19073
\n
(484) 229 – 0750
\n
www.kaskelalaw.com<\/a><\/p>\n

KEYWORDS:<\/b> Pennsylvania United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Class Action Lawsuit Professional Services Legal<\/p>\n

MEDIA:<\/b><\/p>\n\n","protected":false},"excerpt":{"rendered":"

Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm PHILADELPHIA–(BUSINESS WIRE)– Investor litigation firm Kaskela Law announces that it is investigating Integra LifeSciences Holdings Corp. (NASDAQ: IART) (\u201cIntegra\u201d) on behalf of the company\u2019s long-term investors. Click here for additional information: https:\/\/kaskelalaw.com\/cases\/integra-lifesciences\/ Recently a securities fraud complaint was filed against Integra on behalf of investors who purchased shares of the company\u2019s stock between March 11, 2019 and May 22, 2023 (the \u201cWrongdoing Period\u201d). According to the complaint, during the Wrongdoing Period, the company issued a series of materially false and misleading statements to investors concerning \u201cIntegra\u2019s systemic, serious, and recurring violations of current Good Manufacturing Practices (\u201ccGMP\u201d), which are … <\/p>\n

Continue reading “Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-984044","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nKaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm PHILADELPHIA–(BUSINESS WIRE)– Investor litigation firm Kaskela Law announces that it is investigating Integra LifeSciences Holdings Corp. (NASDAQ: IART) (\u201cIntegra\u201d) on behalf of the company\u2019s long-term investors. Click here for additional information: https:\/\/kaskelalaw.com\/cases\/integra-lifesciences\/ Recently a securities fraud complaint was filed against Integra on behalf of investors who purchased shares of the company\u2019s stock between March 11, 2019 and May 22, 2023 (the \u201cWrongdoing Period\u201d). According to the complaint, during the Wrongdoing Period, the company issued a series of materially false and misleading statements to investors concerning \u201cIntegra\u2019s systemic, serious, and recurring violations of current Good Manufacturing Practices (\u201ccGMP\u201d), which are … Continue reading "Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-23T11:38:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260723585891r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm\",\"datePublished\":\"2026-07-23T11:38:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\\\/\"},\"wordCount\":452,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260723585891r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\\\/\",\"name\":\"Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260723585891r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2026-07-23T11:38:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260723585891r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260723585891r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\/","og_locale":"en_US","og_type":"article","og_title":"Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm - Market Newsdesk","og_description":"Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm PHILADELPHIA–(BUSINESS WIRE)– Investor litigation firm Kaskela Law announces that it is investigating Integra LifeSciences Holdings Corp. (NASDAQ: IART) (\u201cIntegra\u201d) on behalf of the company\u2019s long-term investors. Click here for additional information: https:\/\/kaskelalaw.com\/cases\/integra-lifesciences\/ Recently a securities fraud complaint was filed against Integra on behalf of investors who purchased shares of the company\u2019s stock between March 11, 2019 and May 22, 2023 (the \u201cWrongdoing Period\u201d). According to the complaint, during the Wrongdoing Period, the company issued a series of materially false and misleading statements to investors concerning \u201cIntegra\u2019s systemic, serious, and recurring violations of current Good Manufacturing Practices (\u201ccGMP\u201d), which are … Continue reading \"Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-23T11:38:33+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260723585891r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm","datePublished":"2026-07-23T11:38:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\/"},"wordCount":452,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260723585891r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\/","name":"Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260723585891r1&sid=flmnd&distro=nx&lang=en","datePublished":"2026-07-23T11:38:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260723585891r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260723585891r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kaskela-law-firm-announces-investigation-of-integra-lifesciences-iart-and-encourages-long-term-iart-shareholders-with-investment-losses-to-contact-the-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/984044","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=984044"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/984044\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=984044"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=984044"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=984044"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}